Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
Emory University School of Medicine, Atlanta, GA, USA.
Cardiol Young. 2022 Oct;32(10):1592-1597. doi: 10.1017/S1047951121004571. Epub 2021 Nov 29.
Advances in surgical techniques and post-operative management of children with CHD have significantly lowered mortality rates. Unplanned cardiac interventions are a significant complication with implications on morbidity and mortality.
We conducted a single-centre retrospective case-control study for patients (<18 years) undergoing cardiac surgery for repair of Tetralogy of Fallot between January 2009 and December 2019. Data included patient characteristics, operative variables and outcomes. This study aimed to assess the incidence and risk factors for reintervention of Tetralogy of Fallot after cardiac surgery. The secondary outcome was to examine the incidence of long-term morbidity and mortality in those who underwent unplanned reinterventions.
During the study period 29 patients (6.8%) underwent unplanned reintervention, and were matched to 58 patients by age, weight and sex. Median age was 146 days, and median weight was 5.8 kg. Operative mortality was 7%, and 1-year survival was 86% for the entire cohort (cases and controls). Hispanic patients were more likely to have reinterventions (p = 0.04) in the unadjusted analysis, while Asian, Pacific Islander and Native American (p = 0.01) in the multi-variate analysis. Patients that underwent reintervention were more likely to have post-op arrhythmia, genetic syndromes and higher operative and 1-year mortality (p < 0.05).
Unplanned cardiac interventions following Tetralogy of Fallot repair are common, and associated with increased operative, and 1-year mortality. Race, genetic syndromes and post-operative arrhythmia are associated with increased odds of unplanned reinterventions. Future studies are needed to identify modifiable risk factors to minimise unplanned reinterventions.
儿童先天性心脏病(CHD)的外科技术和术后管理的进步显著降低了死亡率。计划外的心脏介入是一种严重的并发症,会影响发病率和死亡率。
我们进行了一项单中心回顾性病例对照研究,纳入了 2009 年 1 月至 2019 年 12 月期间接受法洛四联症心脏手术修复的年龄<18 岁的患者。数据包括患者特征、手术变量和结果。本研究旨在评估心脏手术后法洛四联症再次介入的发生率和危险因素。次要结果是检查那些接受非计划再次介入的患者的长期发病率和死亡率。
在研究期间,29 例(6.8%)患者行非计划再次介入,通过年龄、体重和性别与 58 例患者进行匹配。中位年龄为 146 天,中位体重为 5.8kg。手术死亡率为 7%,整个队列(病例和对照组)的 1 年生存率为 86%。未调整分析中,西班牙裔患者更有可能再次介入(p=0.04),而多变量分析中,亚洲、太平洋岛民和美国原住民患者更有可能再次介入(p=0.01)。再次介入的患者更有可能出现术后心律失常、遗传综合征以及更高的手术和 1 年死亡率(p<0.05)。
法洛四联症修复后计划外的心脏介入很常见,并且与手术和 1 年死亡率增加相关。种族、遗传综合征和术后心律失常与计划外再次介入的几率增加相关。需要进一步研究以确定可改变的风险因素,以尽量减少计划外再次介入。